Passage Bio Inc
NASDAQ:PASG

Watchlist Manager
Passage Bio Inc Logo
Passage Bio Inc
NASDAQ:PASG
Watchlist
Price: 7.44 USD 28.72% Market Closed
Market Cap: 23.1m USD

Wall Street
Price Targets

PASG Price Targets Summary
Passage Bio Inc

Wall Street analysts forecast PASG stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PASG is 4.42 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.

Lowest
Price Target
3.03 USD
59% Downside
Average
Price Target
4.42 USD
41% Downside
Highest
Price Target
6.3 USD
15% Downside
Passage Bio Inc Competitors:
Price Targets
GRAL
Grail Inc
3% Upside
PHM
Pharma Mar SA
16% Upside
ZEAL
Zealand Pharma A/S
128% Upside
FYB
Formycon AG
85% Upside
NRIX
Nurix Therapeutics Inc
165% Upside
ZYME
Zymeworks Inc
71% Upside
IMDX
Insight Molecular Diagnostics Inc
92% Upside
ACLX
Arcellx Inc
60% Upside

Revenue
Forecast

Revenue Estimate
Passage Bio Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Passage Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Passage Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PASG's stock price target?
Price Target
4.42 USD

According to Wall Street analysts, the average 1-year price target for PASG is 4.42 USD with a low forecast of 3.03 USD and a high forecast of 6.3 USD.

Back to Top